Annovis Bio (ANVS) Profit After Tax (2019 - 2026)

Annovis Bio has reported Profit After Tax for 8 years, with the latest figure at -$17.6 million in Q1 2026.

• Quarterly Profit After Tax fell 217.86% year-over-year to -$17.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$41.0 million (down 40.83% YoY) and the FY2025 annual result came in at -$28.9 million, down 17.53% from the prior year.
• Profit After Tax slipped to -$17.6 million in Q1 2026 per ANVS's latest filing, from -$9.9 million in the prior quarter.
• Over five years, Profit After Tax peaked at -$1.1 million in Q1 2024 and troughed at -$22.2 million in Q4 2023.
• A 5-year average of -$9.0 million and a median of -$7.3 million in 2025 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax jumped 89.04% in 2024, then sank 418.96% in 2025.
• Over 5 years, Profit After Tax stood at -$7.7 million in 2022, then sank by 188.58% to -$22.2 million in 2023, then surged by 73.48% to -$5.9 million in 2024, then plunged by 67.73% to -$9.9 million in 2025, then slumped by 78.13% to -$17.6 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$17.6 million, -$9.9 million, and -$7.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.